Invention Grant
- Patent Title: Enhanced ligation reactions
-
Application No.: US16154529Application Date: 2018-10-08
-
Publication No.: US10597705B2Publication Date: 2020-03-24
- Inventor: Stephen Hendricks , David King , Lei Xi , Marian Peris
- Applicant: LIFE TECHNOLOGIES CORPORATION
- Applicant Address: US CA Carlsbad
- Assignee: Life Technologies Corporation
- Current Assignee: Life Technologies Corporation
- Current Assignee Address: US CA Carlsbad
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6853 ; C12Q1/6844 ; C12Q1/6806 ; C12P19/34 ; C12Q1/6869 ; C12Q1/6874 ; C12Q1/6834 ; C12Q1/46

Abstract:
In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends.
Public/Granted literature
- US20190024159A1 ENHANCED LIGATION REACTIONS Public/Granted day:2019-01-24
Information query